Quick Answer
IDEXX LABORATORIES INC /DE reported Operating Income Loss of $1.36 billion for the year ending 2025.
- IDEXX LABORATORIES INC /DE showed an increase of +20.5% in Operating Income Loss from 2024 to 2025.
- This data is from IDEXX LABORATORIES INC /DE's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $65.49 million | Q4 2013: $61.33 million | Q1 2014: $70.05 million | Q2 2014: $83.22 million | Q3 2014: $72.19 million | Q4 2014: $34.80 million | Q1 2015: $72.80 million | Q2 2015: $88.30 million | Q3 2015: $71.90 million | Q4 2015: $66.91 million | Q1 2016: $73.79 million | Q2 2016: $104.16 million | Q3 2016: $88.46 million | Q4 2016: $83.83 million | Q1 2017: $92.24 million | Q2 2017: $122.56 million | Q3 2017: $100.41 million | Q4 2017: $97.81 million | Q1 2018: $113.04 million | Q2 2018: $145.59 million | Q3 2018: $117.35 million | Q4 2018: $115.35 million | Q1 2019: $133.14 million | Q2 2019: $164.28 million | Q3 2019: $139.80 million | Q4 2019: $115.63 million | Q1 2020: $144.33 million | Q2 2020: $193.25 million | Q3 2020: $171.86 million | Q1 2021: $247.62 million | Q2 2021: $259.25 million | Q3 2021: $225.96 million | Q1 2022: $248.34 million | Q2 2022: $179.07 million | Q3 2022: $244.83 million | Q1 2023: $280.40 million | Q2 2023: $296.14 million | Q3 2023: $275.28 million | Q1 2024: $298.96 million | Q2 2024: $263.80 million | Q3 2024: $303.89 million | Q1 2025: $316.53 million | Q2 2025: $373.05 million | Q3 2025: $354.85 million.
- Over the full 18 years of available data (2008 to 2025), IDEXX LABORATORIES INC /DE's Operating Income Loss has grown by 688.6%.
- Historical annual values: Fiscal year 2025: $1.36 billion | Fiscal year 2024: $1.13 billion | Fiscal year 2023: $1.10 billion | Fiscal year 2022: $898.77 million | Fiscal year 2021: $932.03 million | Fiscal year 2020: $694.52 million | Fiscal year 2019: $552.85 million | Fiscal year 2018: $491.34 million | Fiscal year 2017: $413.03 million | Fiscal year 2016: $350.24 million | Fiscal year 2015: $299.91 million | Fiscal year 2014: $260.26 million | Fiscal year 2013: $266.76 million | Fiscal year 2012: $262.56 million | Fiscal year 2011: $236.23 million | Fiscal year 2010: $203.88 million | Fiscal year 2009: $175.97 million | Fiscal year 2008: $172.46 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: